Brain+ A/S, a healthtech company, develops and commercializes technology solutions in dementia care primarily for cognitive stimulation therapy. The company is developing Ayla, a scalable dementia care platform that offers practical, human-centered, and clinically proven software-based dementia therapy and care solutions. It is also developing Ayla – your CST Assistant, a software-based dementia care platform that offers high-quality and scalable cognitive stimulation therapy (CST). The company offers its products to healthcare providers, as well as patients and carers. Brain+ A/S was incorporated in 2012 and is based in Copenhagen, Denmark.
Metrics to compare | BRAINP | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipBRAINPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.9x | −0.6x | −0.6x | |
PEG Ratio | - | 0.00 | 0.00 | |
Price/Book | 0.8x | 1.3x | 2.6x | |
Price / LTM Sales | 2.0x | 1.9x | 3.2x | |
Upside (Analyst Target) | - | 32.7% | 42.3% | |
Fair Value Upside | Unlock | −1.4% | 5.7% | Unlock |